Marfan Syndrome new therapeutic perspectives

21 de April de 2017

The eighth conference of the Santander Biomedical Lectures program organized by IDIVAL, the University of Cantabria and the IBBTEC, will take place on the 27th of April. The conference will be given by Juan Francisco Nistal Herrera, Assistant Physician of the Cardiovascular Surgery Service at Marques de Valdecilla University Hospital and responsible for the group of IDIVAL Cytokines and Growth Factors in Pathological Tissue Plasticity Phenomena.

The session will be about “Advances in molecular Pathophysiology and new therapeutic perspectives in Marfan's disease”.

120 years after the original description, Marfan's disease continues to arouse the interest of clinicians, surgeons and basic researchers. It is the most prevalent of rare diseases which gives it an obvious health interest. In addition, the study of marfan’s disease etiopathogeny has been key to differentiate the diagnosis of several other entities and has given rise to the description of new syndromes. Affected patients present a challenge for clinicians because of the difficulty that sometimes involves the diagnosis, multiorgan involvement, making recommendations regarding physical or reproductive exercise, and establishing surgical indications in young patients or with extreme somatometry. For surgeons, these patients represent a challenge because of the technical difficulty involved in their treatment. The scientific advances of the last two decades allow, on an objective basis, to hopefully modify the molecular pathophysiology of the disease and stop or even reverse the structural pathological changes of the aortic wall and other affected tissues.

The conference will be open to the general public and it will take place at Marques de Valdecilla University Hospital, Salon Tellez (Pavilion 16) at 8.15am.